echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Stroke: What is the difference between warfarin and the four direct oral anticoagulants on the risk of dementia in patients with atrial fibrillation?

    Stroke: What is the difference between warfarin and the four direct oral anticoagulants on the risk of dementia in patients with atrial fibrillation?

    • Last Update: 2021-09-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Atrial fibrillation is a risk factor for dementia, and the use of oral anticoagulants is related to the reduced risk of dementia in patients with atrial fibrillation
    .

    Recently, the heart blood vessels published a research article on the disease areas authoritative journal Stroke, researchers to investigate patients receiving (DOAC) direct oral anticoagulant treatment compared with patients receiving warfarin therapy, the risk of dementia Is it different
    .

    Heart blood vessels

    The researchers used the Korean National Claims Database from January 2014 to December 2017 to identify non-valvular atrial fibrillation patients over 40 years of age who did not use oral anticoagulants
    .


    For comparison, the warfarin group and the DOAC group were balanced using a treatment-weighted inverse probability method


    The study included 72,846 patients, 25,948 received warfarin, 46,898 received DOAC (17,193 rivaroxaban, 9882 dabigatran, 11992 apixaban , 7831 edoxaban )
    .


    During an average follow-up of 1.


    Apixaban stroke In this large Asian AF population, overall, DOAC has a risk of dementia similar to that of warfarin


    Original source:

    So-Ryoung Lee.


    et al.
    Comparing Warfarin and 4 Direct Oral Anticoagulants for the Risk of Dementia in Patients With Atrial Fibrillation .
    stroke.
    2021.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.